Effect of chemotherapeutic agents on bladder cancer: a new animal model.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D003959:Diamines / Q000627:therapeutic use; D004195:Disease Models, Animal; D004317:Doxorubicin / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006918:Hydroxyurea / Q000627:therapeutic use; D008130:Lomustine / Q000627:therapeutic use; D051379:Mice; D008809:Mice, Inbred C3H; D010984:Platinum / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D003959:Diamines; D003609:Dactinomycin; D010984:Platinum; D008130:Lomustine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D006918:Hydroxyurea